Strides Pharma Science Ltd. engages in the development, manufacture and distribution of Internet Protocol-led generics and bio-pharmaceutical products. It operates through the Pharmaceutical and Bio-pharmaceutical business segments. The company was founded by Arun N. Kumar on June 28, 1990 and is headquartered in Bangalore, India.
STRIDES PHARMA SCI LTD financial statements, including revenue, expenses, and profit: The total revenue of STAR for the last quarter is 11.20 B INR, and it's 5.94% lower compared to the previous quarter. The net income of Q1 25 is 996.08 M INR.
STRIDES PHARMA SCI LTD key financial stats and ratios: STAR price-to-sales ratio is 1.62. The company has an Enterprise Value to EBITDA ratio of 8.58. As of 2024 they employed 5.18 k people.
STRIDES PHARMA SCI LTD dividends overview: STAR dividends are paid annually. The last dividend per share was 4.00 INR. As of today, Dividend Yield (TTM)% is 0.49%.
STRIDES PHARMA SCI LTD earnings per share and revenue: Company revenue for the same period amounts to 11.20 B INR despite the estimated figure of 12.01 B INR. Also watch annual changes over time to get a bigger picture of STAR earnings per share and revenue dynamics.
STRIDES PHARMA SCI LTD revenue breakdown overview: STRIDES PHARMA SCI LTD revenue for the last year amounted to 45.65 B INR, the most of which — 45.65 B INR — came from its highest performing source at the moment, Pharmaceutical, the year earlier bringing 40.51 B INR. The greatest contribution to the revenue figure was made by North America — last year it brought STRIDES PHARMA SCI LTD 24.51 B INR, and the year before that — 21.48 B INR.
Potential 50% Upside with Entry Price 775 Target Price 1165, Timeframe 6-12 Months
Comments
Post a Comment